Follow The Filings

MANH Manhattan Associates

Manhattan Associates earnings company data as of 8:00 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 1.03 — —
Rev — — —

Insider trades

Open-market buys and sales by MANH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MANH insider trades
  • None no insider bought on the open market
  • $3.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Eric Andrew Clark CEO
    Sale
    $593K 3,000 shares at $197.76 3.2% of stake
    Traded Aug 11 Filed Aug 11
  2. Linda T. Hollembaek Director
    Sale
    $300K 1,579 shares at $189.88 11% of stake
    Traded Aug 6 Filed Aug 10
  3. James Stewart Gantt EVP, Professional Services
    Sale
    $1M 5,139 shares at $195.53 8.5% of stake
    Traded Jul 30 Filed Jul 31
  4. Eric Andrew Clark CEO
    Sale
    $147K 1,000 shares at $146.77 1.1% of stake
    Traded Jun 10 Filed Jun 10
  5. James Stewart Gantt EVP, Professional Services
    Sale
    $1M 7,300 shares at $139.25 11% of stake
    Traded Apr 24 Filed Apr 24
  6. Eric Andrew Clark CEO
    Sale
    $282K 1,600 shares at $176.40 3.1% of stake
    Traded Nov 28, 2025 Filed Dec 1, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 stock grants, 15 share withholdings for taxes, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 2.05,7.01
8-K 5.02,9.01
8-K 5.07
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
DEFA14A
8-K 2.02,9.01
DEF 14A
DEFA14A
8-K/A 5.02,9.01
SCHEDULE 13G/A —
8-K 5.02,7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.